Tekla Life Sciences Investors operates in the Investment offices sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tekla Life Sciences Investors with three other
companies in this sector in UNITED STATES :
BlackRock Municipal Income Trust
(2020
sales of $36.87 million
),
Invesco Advantage Municipal Income Trust II
($36.85 million
), and
Gladstone Capital Corporation
($39.07 million
of which 100%
was Investment Income).
Sales Analysis.
Tekla Life Sciences Investors reported sales of $39.07 million
for the
fiscal
year ending
September of 2020.
This
represents
a
decrease of 0.0%
versus 2019, when the company's sales were $39.09 million.